Synthesis, Characterization, and Biological Evaluation of Some Novel Pyrazolo[5,1-b]thiazole Derivatives as Potential Antimicrobial and Anticancer Agents. 2021

Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia.

The pharmacological activities of thiazole and pyrazole moieties as antimicrobial and anticancer agents have been thoroughly described in many literature reviews. In this study, a convenient synthesis of novel pyrazolo[5,1-b]thiazole-based heterocycles was carried out. The synthesized compounds were characterized by IR, 1H and 13C NMR spectroscopy and mass spectrometry. Some selected examples were screened and evaluated for their antimicrobial and anticancer activities and showed promising results. These products could serve as leading compounds in the future design of new drug molecules.

UI MeSH Term Description Entries
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D045325 HCT116 Cells Human COLORECTAL CARCINOMA cell line. HCT 116 Cells,HCT-116 Cells,Cell, HCT 116,Cell, HCT-116,Cell, HCT116,Cells, HCT 116,Cells, HCT-116,Cells, HCT116,HCT 116 Cell,HCT-116 Cell,HCT116 Cell
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell

Related Publications

Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
July 2008, Archiv der Pharmazie,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
February 2019, Molecules (Basel, Switzerland),
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
November 2018, Molecules (Basel, Switzerland),
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
May 2009, Archiv der Pharmazie,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
July 2021, Molecules (Basel, Switzerland),
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
August 2016, Bioorganic chemistry,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
October 2004, Bollettino chimico farmaceutico,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
January 2007, Arzneimittel-Forschung,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
April 2010, European journal of medicinal chemistry,
Abdulrhman Alsayari, and Abdullatif Bin Muhsinah, and Yahya I Asiri, and Faiz A Al-Aizari, and Nabila A Kheder, and Zainab M Almarhoon, and Hazem A Ghabbour, and Yahia N Mabkhot
March 2006, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!